Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2020-10-22

Clinical Trial Update: Double-blind, Randomized Controlled Study to Assess the Analgesic Effect of 2 g of Magnesium Dipyrone (Metamizol) and Changes in Plasma Beta-endorphin Immunoreactivity Values in Patients Undergoing Elective Inguinal Herniorrhaphy Under Epidural Anesthesia. [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind study evaluating the analgesic effect of 2 g of metamizol (magnesium dipyrone) and its impact on plasma beta-endorphin levels…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metamizol (magnesium dipyrone) (metamizol)

Snippet

Sponsor: Antonio Martín Duce | Conditions: Pain, Beta-endorphin | Phase 4 | Status: COMPLETED